Other treatment approaches for preventive strategies may represent, for instance, the use of tolerogenic dendritic cells82 or targeting the IL-17/23 axis83 in order to block arthritis development in pre-clinical phases of the disease. The gene discussed is IL17A; the disease is arthritic joint disease.